Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial

Additional Metadata
Persistent URL	doi.org/10.1067/mhj.2000.105107, hdl.handle.net/1765/55828
Journal	American Heart Journal
Organisation	Department of Neurology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Topol, E., Easton, D., Amarenco, P., Califf, R., Harrington, R. A., Graffagnino, C., Davis, S., Diener, H. C., Ferguson, J., Fitzgerald, D., Shuaib, A., Koudstaal, P., Théroux, P., van de Werf, F., Willerson, J., Chan, R., Samuels, J., Ilson, D.& Granett, J. (2000). Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. American Heart Journal, 139(6), 927–933.https://doi.org/10.1067/mhj.2000.105107

Publication